The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six months

التفاصيل البيبلوغرافية
العنوان: The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six months
المؤلفون: Sarah Pountain, Khalid Ali, Martin W. Allen, Anushka Warusevitane, Frank Lally, Tracy Nevatte, Sheila Sills, Christine Roffe, Julius Sim
المصدر: PLoS ONE, Vol 8, Iss 6, p e59274 (2014)
PLoS ONE
بيانات النشر: Public Library of Science (PLoS), 2014.
سنة النشر: 2014
مصطلحات موضوعية: Male, Activities of daily living, Time Factors, Non-Clinical Medicine, lcsh:Medicine, Pilot Projects, Cardiovascular, law.invention, Randomized controlled trial, Modified Rankin Scale, law, Surveys and Questionnaires, Activities of Daily Living, lcsh:Science, Multidisciplinary, Rehabilitation, RC666, Stroke, Treatment Outcome, Neurology, Medicine, Female, medicine.symptom, Research Article, medicine.medical_specialty, Clinical Research Design, Cerebrovascular Diseases, Odds, Memory, Statistical significance, Internal medicine, medicine, Humans, Clinical Trials, Survival analysis, Aged, Ischemic Stroke, Health Care Policy, business.industry, lcsh:R, Odds ratio, Hypoxia (medical), RC0952, Survival Analysis, Oxygen, Geriatrics, Physical therapy, Quality of Life, lcsh:Q, business
الوصف: Introduction: Post-stroke hypoxia is common, and may adversely affect outcome. We have recently shown that oxygen supplementation may improve early neurological recovery. Here, we report the six-month outcomes of this pilot study.\ud \ud Methods: Patients with a clinical diagnosis of acute stroke were randomized within 24 h of admission to oxygen supplementation at 2 or 3 L/min for 72 h or to control treatment (room air). Outcomes (see below) were assessed by postal questionnaire at 6 months. Analysis was by intention-to-treat, and statistical significance was set at p#0.05.\ud \ud Results: Out of 301 patients randomized two refused/withdrew consent and 289 (148 in the oxygen and 141 in the control group) were included in the analysis: males 44%, 51%; mean (SD) age 73 (12), 71 (12); median (IQR) National Institutes of Health Stroke Scale score 6 (3, 10), 5 (3, 10) for the two groups respectively. At six months 22 (15%) patients in the oxygen group and 20 (14%) in the control group had died; mean survival in both groups was 162 days (p= 0.99). Median (IQR) scores for the primary outcome, the modified Rankin Scale, were 3 (1, 5) and 3 (1, 4) for the oxygen and control groups respectively. The covariate-adjusted odds ratio was 1.04 (95% CI 0.67, 1.60), indicating that the odds of a lower (i.e. better) score were non-significantly higher in the oxygen group (p= 0.86). The mean differences in the ability to perform basic (Barthel Index) and extended activities of daily living (NEADL), and quality of life (EuroQol) were also non-significant.\ud \ud Conclusions: None of the key outcomes differed at 6 months between the groups. Although not statistically significant and generally of small magnitude, the effects were predominantly in favour of the oxygen group; a larger trial, powered to show differences in longer-term functional outcomes, is now on-going.\ud \ud Trial Registration: Controlled-Trials.com ISRCTN12362720; Eudract.ema.europa.eu 2004-001866-41
وصف الملف: application/pdf
اللغة: English
تدمد: 1932-6203
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646c497ae701a0e530aaaf3f3768b7a6
http://europepmc.org/articles/PMC3670882?pdf=render
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....646c497ae701a0e530aaaf3f3768b7a6
قاعدة البيانات: OpenAIRE